Dermatologic Manifestations of Mycobacterium Marinum Infection of the Skin
- Author: Joslyn S Kirby, MD; Chief Editor: Dirk M Elston, MD more...
Mycobacterium marinum is an atypical Mycobacterium found in salt water and fresh water. M marinum is the most common atypical Mycobacterium to cause infection in humans. Infection occurs following inoculation of a skin abrasion or puncture and manifests as a localized granuloma or sporotrichotic lymphangitis (see the image below).
Diagnosis and treatment are often delayed because of a lack of suspicion for mycobacterial involvement, ie, versus more common bacterial pathogens. Due to the increased use of immunosuppressants for transplant recipients and tumor necrosis factor (TNF) inhibitors for a variety of conditions, infections with mycobacteria other than tuberculosis (MOTT) are increasing.
M marinum infection occurs following trauma to an extremity that is in contact with an aquarium, salt water, or marine animals such as fish or turtles. Exposure to M marinum via swimming pools is rare because most pools are chlorinated.
The pathogen is classified as a photochromagen in Runyon group 1, which means that it produces yellow pigment when cultured and exposed to light. Culture growth occurs over 7-21 days and is optimal at 25-32°C (77-89.6°F) given the organism is adapted to infect ectotherms, such as fish. When endotherms, such as humans, are infected the infection favors the cooler extremities more than central sites. Systemic infection, usually of an immunocompromised host, has been reported. This indicates that the organism is capable of adapting to grow in conditions closer to 37°C.
After inoculation into the host tissues via an abrasion or other wound, the mycobacteria are phagocytosed by macrophages. Inside the macrophage, they are able to interrupt the formation of the phagolysosome, which would normally kill the organisms. The mycobacteria, however, are able escape the lysosome and can move intracellularly and extracellularly via actin-based motility. This may contribute to cell-to-cell spread.
Tumor necrosis factor (TNF) is important for the immune response against mycobacteria. Studies have demonstrated that in the absence of TNF, macrophages engulf but do not destroy the mycobacteria. Instead, the mycobacteria survive and grow, finally killing the macrophage. The importance of TNF is also supported by a number of reports of infection occurring in patients treated with TNF inhibitors.[3, 4, 5]
Studies have revealed 2 pathophysiologically and genetically (ie, via amplified restriction-based polymorphism analysis) distinct populations of M marinum. One group can infect humans and causes acutely lethal disease in fish, while a second group cannot infect humans and causes chronic progressive disease in fish.
Utility of M marinum as an immunotherapy agent to elicit an antituberculosis response is currently being explored.
Infections caused by M marinum are uncommon but well described in the literature. The estimated annual incidence is 0.27 cases per 100,000 adult patients. Of the more than 160 cases described, most are case reports of cutaneous infection; some report concomitant osteomyelitis, tenosynovitis, arthritis, and/or disseminated infection. Nosocomial infection has never been described.
Infection occurs worldwide, most commonly in individuals with occupational and recreational exposure to nonchlorinated fresh water or salt water.
M marinum skin infection typically remains localized and does not cause significant morbidity in patients who are immunocompetent. Cases reported in patients who are severely immunocompromised document disseminated infection involving the bone marrow and viscera with rare reports of death secondary to the infection.
No racial predilection is apparent for M marinum skin infection.
No sexual predilection has been noted for M marinum skin infection.
M marinum infection has been reported in persons of every age group; however, it appears to be rare in the pediatric population.
Kent ML, Watral V, Wu M, Bermudez LE. In vivo and in vitro growth of Mycobacterium marinum at homoeothermic temperatures. FEMS Microbiol Lett. 2006 Apr. 257(1):69-75. [Medline].
Clay H, Volkman HE, Ramakrishnan L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity. 2008 Aug 15. 29(2):283-94. [Medline].
Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect. 2007 Dec. 55(6):484-7. [Medline].
Levesque BG, Sandborn WJ. Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease. Inflamm Bowel Dis. 2011 Jun. 17(6):1443-4. [Medline].
Kump PK, Högenauer C, Wenzl HH, Petritsch W. A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease. J Crohns Colitis. 2013 Feb. 7(1):e15-8. [Medline].
Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med. 2002 Aug 12-26. 162(15):1746-52. [Medline].
Doedens RA, van der Sar AM, Bitter W, Scholvinck EH. Transmission of Mycobacterium marinum from fish to a very young child. Pediatr Infect Dis J. 2008 Jan. 27(1):81-3. [Medline].
Appelgren P, Farnebo F, Dotevall L, Studahl M, Jonsson B, Petrini B. Late-onset posttraumatic skin and soft-tissue infections caused by rapid-growing mycobacteria in tsunami survivors. Clin Infect Dis. 2008 Jul 15. 47(2):e11-6. [Medline].
Ko DY, Song KH. Mycobacterium marinum infection occurring on the face. J Dermatol. 2013 Sep. 40(9):773-4. [Medline].
Bouricha M, Castan B, Duchene-Parisi E, Drancourt M. Mycobacterium marinum infection following contact with reptiles: vivarium granuloma. Int J Infect Dis. 2014 Apr. 21C:17-18. [Medline].
S Breza T Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections. J Cutan Pathol. 2006 Jul. 33(7):512-5. [Medline].
Lam A, Toma W, Schlesinger N. Mycobacterium marinum arthritis mimicking rheumatoid arthritis. J Rheumatol. 2006 Apr. 33(4):817-9. [Medline].
Janik JP, Bang RH, Palmer CH. Case reports: successful treatment of Mycobacterium marinum infection with minocycline after complication of disease by delayed diagnosis and systemic steroids. J Drugs Dermatol. 2005 Sep-Oct. 4(5):621-4. [Medline].
Gluckman SJ. Mycobacterium marinum. Clin Dermatol. 1995 May-Jun. 13(3):273-6. [Medline].
Bhambri S, Bhambri A, Del Rosso JQ. Atypical mycobacterial cutaneous infections. Dermatol Clin. 2009 Jan. 27(1):63-73. [Medline].
Mahaisavariya P, Chaiprasert A, Manonukul J, Khemngern S, Tingtoy N. Detection and identification of Mycobacterium species by polymerase chain reaction (PCR) from paraffin-embedded tissue compare to AFB staining in pathological sections. J Med Assoc Thai. 2005 Jan. 88(1):108-13. [Medline].
Ho MH, Ho CK, Chong LY. Atypical mycobacterial cutaneous infections in Hong Kong: 10-year retrospective study. Hong Kong Med J. 2006/January. 12:21-6.
Nolte O, Haag H, Hafner B. A mutation in the 65,000 Dalton heat shock protein gene, commonly used for molecular identification of non-tuberculous mycobacteria, leads to the misidentification of Mycobacterium malmoense as Mycobacterium marinum. Mol Cell Probes. 2005 Aug. 19(4):275-7. [Medline].
Lai CC, Tan CK, Lin SH, Liu WL, Liao CH, Huang YT, et al. Diagnostic value of an enzyme-linked immunospot assay for interferon-? in cutaneous tuberculosis. Diagn Microbiol Infect Dis. 2011 May. 70(1):60-4. [Medline].
Wongworawat MD, Holtom P, Learch TJ, Fedenko A, Stevanovic MV. A prolonged case of Mycobacterium marinum flexor tenosynovitis: radiographic and histological correlation, and review of the literature. Skeletal Radiol. 2003 Sep. 32(9):542-5. [Medline].
Rybniker J, Kramme S, Small PL. Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis--application for identification and susceptibility testing. J Med Microbiol. 2006 Jan. 55:37-42. [Medline].
Travis WD, Travis LB, Roberts GD, Su DW, Weiland LW. The histopathologic spectrum in Mycobacterium marinum infection. Arch Pathol Lab Med. 1985 Dec. 109(12):1109-13. [Medline].
Rallis E, Koumantaki-Mathioudaki E. Treatment of Mycobacterium marinum cutaneous infections. Expert Opin Pharmacother. 2007 Dec. 8(17):2965-78. [Medline].
Bhatty MA, Turner DP, Chamberlain ST. Mycobacterium marinum hand infection: case reports and review of literature. Br J Plast Surg. 2000 Mar. 53(2):161-5. [Medline].
Sato E, Imafuku S, Ishii K, Itoh R, Chou B, Soejima T, et al. Vitamin D-dependent cathelicidin inhibits Mycobacterium marinum infection in human monocytic cells. J Dermatol Sci. 2013 Jun. 70(3):166-72. [Medline].
Cummins DL, Delacerda D, Tausk FA. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol. 2005 Jun. 44(6):518-20. [Medline].
Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases. J Am Acad Dermatol. 2007 Sep. 57(3):413-20. [Medline].
Parrish N, Luethke R, Dionne K, Carroll K, Riedel S. Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics. J Clin Microbiol. 2011 May. 49(5):2056-8. [Medline].
Seneviratne K, Herieka E. A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual. Int J STD AIDS. 2013 Jan. 24(1):75-7. [Medline].